Kronos Bio Presents Positive Preliminary Data from Phase 1 Dose Escalation Portion of … – BioSpace

SAN MATEO, Calif. and CAMBRIDGE, Mass., Oct. 13, 2023 (GLOBE NEWSWIRE) — Kronos Bio Inc, (Nasdaq: KRON), a company dedicated to transforming the …